We processed Tofacitinib CAS 477600-75-2 is strictly according to industry standard. The specification is micronized and on sterile level. Tofacitinib CAS NO 477600-75-2 is widely used to treatment of rheumatoid arthritis (RA). Apart from this, It also has demonstrated effectiveness in the treatment of psoriasis in Phase 3 studies, and is being studied for treatment of inflammatory bowel disease, and other immunological diseases, as well as for the prevention of organ transplant rejection.
Thera. Category: Treatment of rheumatoid arthritis
Cas No.: 477600-75-2
Synonyms: 3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile;CP 690550;3-Piperidinamine, 1-(cyanoacetyl)-4-methyl-N-methyl-N-1H-pyrrolo(2,3-D)pyrimidin-4-yl-, (3R,4R)-;CP-690550(Tasocitinib,CP690550);CP 690550(Tasocitinib);Tasocitinib;3-((3R,4R)-4-Methyl-3-(Me...;Tasocitinib (CP 690550)
Molecular Formula: C16H20N6O
Molecular Weight: 312.3696
Assay: ≥99%
Packing: Export worthy packing
Material Safety Data Sheet: Available on request
Usage: As Janus kinase inhibitor for treatment of rheumatoid arthritis